Company profile

CellmAbs company profile

CellmAbs is a NOVA University of Lisbon spin-off company that was founded in 2019 with the funding of two of Portugal's top Life Science Venture Capital firms. CellmAbs is a rapidly expanding biotech firm with an international, experienced team that has developed multiple preclinical candidates targeting solid tumors based on a world-class understanding of cancer-specific glycan targets.v

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2019-06-05

Headquarters

Headquarters
Neuhof, Warmia-Masuria, Poland
Postal code
2510 216
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.6M
Last funding
Seed / $1.6M / 2019-06-25
Last equity funding
Seed / $1.6M
Investors
2
Lead investors
1
Founders
2
Articles
5

Founders and investors

Founders

Nuno Prego RamosPaula Videira

Lead investors

Portugal Ventures

Investors

Bionova CapitalPortugal Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.